A detailed history of Wells Fargo & Company transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 25,964 shares of SAGE stock, worth $134,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,964
Previous 24,702 5.11%
Holding current value
$134,233
Previous $268,000 30.22%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.02 - $13.08 $8,859 - $16,506
1,262 Added 5.11%
25,964 $187,000
Q2 2024

Aug 13, 2024

BUY
$10.58 - $17.9 $78,080 - $132,102
7,380 Added 42.6%
24,702 $268,000
Q1 2024

May 10, 2024

BUY
$18.62 - $26.95 $26,440 - $38,269
1,420 Added 8.93%
17,322 $324,000
Q4 2023

Feb 09, 2024

SELL
$17.1 - $22.26 $1.23 Million - $1.61 Million
-72,207 Reduced 81.95%
15,902 $344,000
Q3 2023

Nov 13, 2023

BUY
$16.75 - $48.98 $564,140 - $1.65 Million
33,680 Added 61.88%
88,109 $1.81 Million
Q2 2023

Aug 15, 2023

BUY
$40.65 - $59.54 $129,836 - $190,170
3,194 Added 6.23%
54,429 $2.56 Million
Q1 2023

May 12, 2023

BUY
$37.27 - $46.57 $1.55 Million - $1.93 Million
41,512 Added 426.95%
51,235 $2.15 Million
Q4 2022

Feb 13, 2023

SELL
$32.2 - $43.61 $85,780 - $116,177
-2,664 Reduced 21.51%
9,723 $370,000
Q3 2022

Nov 14, 2022

BUY
$32.28 - $43.27 $316,828 - $424,695
9,815 Added 381.61%
12,387 $485,000
Q2 2022

Aug 12, 2022

BUY
$27.52 - $37.99 $28,070 - $38,749
1,020 Added 65.72%
2,572 $83,000
Q1 2022

May 16, 2022

BUY
$30.71 - $45.71 $9,397 - $13,987
306 Added 24.56%
1,552 $52,000
Q4 2021

Feb 14, 2022

SELL
$37.06 - $47.11 $2.71 Million - $3.44 Million
-73,097 Reduced 98.32%
1,246 $53,000
Q3 2021

Nov 15, 2021

SELL
$40.26 - $57.37 $2.01 Million - $2.87 Million
-49,993 Reduced 40.21%
74,343 $3.29 Million
Q2 2021

Aug 16, 2021

BUY
$54.88 - $79.29 $1.14 Million - $1.65 Million
20,820 Added 20.11%
124,336 $7.06 Million
Q1 2021

May 13, 2021

SELL
$70.65 - $96.76 $158,326 - $216,839
-2,241 Reduced 2.12%
103,516 $7.75 Million
Q4 2020

Feb 09, 2021

SELL
$58.41 - $89.06 $2.24 Million - $3.41 Million
-38,308 Reduced 26.59%
105,757 $9.15 Million
Q3 2020

Nov 05, 2020

BUY
$41.13 - $62.45 $600,045 - $911,083
14,589 Added 11.27%
144,065 $8.81 Million
Q2 2020

Aug 13, 2020

BUY
$25.95 - $43.15 $363,663 - $604,704
14,014 Added 12.14%
129,476 $5.38 Million
Q1 2020

May 14, 2020

BUY
$26.15 - $77.24 $3.02 Million - $8.92 Million
115,462 New
115,462 $3.32 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $307M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.